HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Convergence Investment Partners, LLC's Holding History (CIK: 0001456133)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 30,851 Value ($000) $2,076 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 20,085 Value ($000) $1,473 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 27,475 Value ($000) $1,429 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 28,539 Value ($000) $1,821 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 34,713 Value ($000) $1,660 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 27,562 Value ($000) $1,578 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 26,246 Value ($000) $1,374 Avg Close $43.86 Range $37.73 - $53.00
Q4 2023
Shares 7,008 Value ($000) $0 Avg Close $37.66 Range $32.83 - $42.82
Q4 2015
Shares 172,134 Value ($000) $2,983 Avg Close $15.94 Range $12.80 - $18.65
Q3 2015
Shares 251,748 Value ($000) $3,381 Avg Close $20.08 Range $12.80 - $25.25